HIKMA INTL PHARMS FDA Approval ANDA 076813

ANDA 076813

HIKMA INTL PHARMS

FDA Drug Application

Application #076813

Application Sponsors

ANDA 076813HIKMA INTL PHARMS

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET, EXTENDED RELEASE;ORAL60MG0ISOSORBIDE MONONITRATEISOSORBIDE MONONITRATE
002TABLET, EXTENDED RELEASE;ORAL30MG0ISOSORBIDE MONONITRATEISOSORBIDE MONONITRATE

FDA Submissions

ORIG1AP2005-01-07
LABELING; LabelingSUPPL2AP2006-03-30
LABELING; LabelingSUPPL12AP2015-11-30STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL12Null15

CDER Filings

HIKMA INTL PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 76813
            [companyName] => HIKMA INTL PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"ISOSORBIDE MONONITRATE","activeIngredients":"ISOSORBIDE MONONITRATE","strength":"60MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"ISOSORBIDE MONONITRATE","activeIngredients":"ISOSORBIDE MONONITRATE","strength":"30MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ISOSORBIDE MONONITRATE","submission":"ISOSORBIDE MONONITRATE","actionType":"60MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"ISOSORBIDE MONONITRATE","submission":"ISOSORBIDE MONONITRATE","actionType":"30MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.